Glanbia plc 2016 Full Year Results Presentation 22 February 2017 - - PowerPoint PPT Presentation

glanbia plc
SMART_READER_LITE
LIVE PREVIEW

Glanbia plc 2016 Full Year Results Presentation 22 February 2017 - - PowerPoint PPT Presentation

Glanbia plc 2016 Full Year Results Presentation 22 February 2017 Siobhan Talbot Mark Garvey Group Managing Director Group Finance Director Cautionary Statement Full Year 2016 Performance Summary 87.66c Seventh consecutive year of double


slide-1
SLIDE 1

Siobhan Talbot Group Managing Director

22 February 2017

Mark Garvey Group Finance Director

Glanbia plc 2016 Full Year Results Presentation

slide-2
SLIDE 2

Cautionary Statement

slide-3
SLIDE 3

Strong cash conversion Seventh consecutive year of double digit growth in adjusted EPS Strong EBITA growth across the Group Continued EBITA margin progression across the Group

Full Year 2016 Performance Summary

2016 Full Year Results | Slide 3

  • Adj. EPS

EBITA EBITA margin Free cash flow

87.66c

+11.2% (cc*) +10.8% (rc*)

€305.1m 10.7% €311.0m

+12.5% (cc*) +12.6% (rc*) +90 bps (cc*) +90 bps (rc*) +21.5%

  • *CC denotes constant currency; RC denotes reported currency
  • To arrive at the Constant Currency change, the average FX rate for the current period is applied to the relevant reported result from the same

period in the prior year. The average Euro US Dollar FX rate for 2016 was €1 = $1.107 (FY 2015: €1 = $1.109).

  • This presentation contains certain alternative performance measures. A detailed glossary of the key performance indicators and non-IFRS

performance measures can be found in the appendix of this presentation.

slide-4
SLIDE 4

2016 Full Year Results | Slide 4

Group EBITA progression

Total group EBITA growth +12.8% (cc*), +12.6% (rc*)

Commentary

FY 2016 FY 2015

GLANBIA PERFORMANCE NUTRITION GLANBIA NUTRITIONALS JVs & ASSOCIATES DAIRY IRELAND GLANBIA GROUP TOTAL

* CC denotes constant currency; RC denotes reported currency

€310.7m €349.8m

€135.6m €106.6m €39.7m €28.8m €162.6m €111.8m €44.7m €30.7m

slide-5
SLIDE 5

Strategic Initiatives

Proposal to sell 60% of Dairy Ireland to Glanbia Coop Proposed JV in Michigan

2016 Full Year Results | Slide 5

GPN acquisitions

Amazing Grass and Body & Fit

JV&A’s

slide-6
SLIDE 6

2016 Full Year Results | Slide 6

Strategic rationale and timing

Creates integrated Irish based business of scale – largest Irish dairy processor Builds on the successful partnership of Glanbia plc and Glanbia Coop created in 2012 Strategic logic to create one integrated organisation to maximise opportunities from anticipated growth in Irish milk Investing €250 - €300 million in strategic investment projects to 2020 for future growth largely funded by JV bank debt

Key proposals

Non binding memorandum of understanding signed Expected consideration to plc of €112 million for 60% equity interest. Pension obligations to transfer to new entity and working capital to be acquired separately at completion New entity to be named “Glanbia Ireland”

  • Encompassing Glanbia Ingredients Ireland,

Consumer Products and Agribusiness Ownership of Glanbia Ireland 60% Glanbia Coop 40% Glanbia plc

Proposal to sell 60% of Dairy Ireland to Glanbia Coop

slide-7
SLIDE 7

New Development Project - Joint Venture

50/50 JV in Michigan

2016 Full Year Results | Slide 7

  • Advanced discussions with three major Michigan

Co-ops

  • Commissioning expected in late 2019
  • Development will help Glanbia to maintain

leadership position in US Cheese and advanced technology whey

  • Project cost expected to be $400m to $425m

with the majority of the cost to be financed through debt facilities within the JV

slide-8
SLIDE 8

Acquisitions announced in 2017

2016 Full Year Results | Slide 8

  • Plant-based nutrition, Greens & Super Foods
  • Positions GPN within high growth category
  • Distribution – natural, online & FDM – North America
  • Direct to consumer “DTC” online brand
  • Consumer base is largely in the Netherlands,

Belgium and Germany

  • Providing GPN with access to the rapidly developing

DTC channel

slide-9
SLIDE 9

Operational Review

slide-10
SLIDE 10

Innovation

Glanbia Performance Nutrition

2016 Full Year Results | Slide 10

Performance Growth Earnings Expansion

Strong performance in 2016 Branded revenue growth

13.6% branded revenue growth

Successful launches across the portfolio in ready-to-eat

REVENUE

€1,00 1,007.5m 7.5m

+9.7% (cc) +9.1% (rc)

lfl branded growth

Rev. . +2 +2.6% .6% Vol.

  • l. +6

+6.1% .1%

EBITA

€16 162.6m 2.6m

+20.0% (cc) +19.9% (rc)

EBITA margin

16.1% 16.1%

+130bps (cc) +140bps (rc)

20% Increase in EBITA 130 basis points margin expansion

slide-11
SLIDE 11

Glanbia Nutritionals

2016 Full Year Results | Slide 11

Performance

Good Performance in 2016

Growth

4.5% EBITA growth with strong H2

Value Expansion

Continued growth in value- added Nutritional Solutions 30 basis points margin expansion

REVENUE

€1,22 ,224.2m .2m

+0.4% (cc) +0.5% (rc)

EBITA

€11 111.8m 1.8m

+4.5% (cc) +4.9% (rc)

EBITA margin

9.1% .1%

+30bps (cc) +30bps (rc)

Project to create one customer- facing organisation complete

slide-12
SLIDE 12

Dairy Ireland & JVA’s

DAIRY IRELAND JOINT VENTURES & ASSOCIATES

REVENUE EBITA EBITA margin REVENUE EBITA EBITA margin

2016 Full Year Results | Slide 12

Good performance driven by value- added products Strengthening of margins as a result

  • f cost improvements and increased

value-added sales Strong performance driven by volume growth EBITA growth across all three strategic Joint Ventures

slide-13
SLIDE 13

Finance Review

slide-14
SLIDE 14

Summary Income Statement

2016 Full Year Results | Slide 14

Seventh year of double-digit earnings growth

Reported currency €'m 2016 2015 Change

Revenue (Wholly-owned) 2,847.9 2,774.3 +2.7% EBITA (Wholly-owned) 305.1 271.0 +12.6% EBITA margin 10.7% 9.8% +90 bps

Amortisation of intangibles Net finance costs Share of JV&As Income tax (39.7) (22.8) 27.6 (43.3) (31.1) (21.1) 26.3 (37.3)

Profit for the year 226.9 207.8 Adjusted Earnings per Share 87.66c 79.14c +10.8%

Constant currency Change

+2.8% +12.5% +90 bps +11.2%

2016 results summary pre-exceptional

slide-15
SLIDE 15

Segmental Summary

2016 Full Year Results | Slide 15

Strong performance led by Glanbia Performance Nutrition

FY 2016 €'m Revenue EBITA Margin

Glanbia Performance Nutrition 1,007.5 162.6 16.1% Glanbia Nutritionals 1,224.2 111.8 9.1% Dairy Ireland 616.2 30.7 5.0% Total wholly-owned 2,847.9 305.1 10.7%

Constant currency change Revenue EBITA Margin

+9.7% 20.0% +130 bps +0.4% 4.5% +30 bps

  • 2.7%

6.6% +50 bps +2.8% 12.5% +90 bps

slide-16
SLIDE 16

Revenue Growth by Segment

2016 Full Year Results | Slide 16

€2,600 €2,650 €2,700 €2,750 €2,800 €2,850 €2,900

FY15 FX Glanbia Performance Nutrition Glanbia Nutritionals Dairy Ireland FY16 €2,774m (0.1)% 3.2% 0.2% (0.6)%

* Constant Currency (CC) excluding the impact of FX

€2,848m Million

Wholly owned Revenue growth +2.7% (+2.8% CC*)

slide-17
SLIDE 17

Revenue Growth by Segment - GPN

2016 Full Year Results | Slide 17

€750 €800 €850 €900 €950 €1,000 €1,050

FY15 FX Volume Price Acquisitions FY16 €923m (0.6)% 5.0% (4.8)% 9.5% €1,007m Million

Glanbia Performance Nutrition Revenue growth +9.1% (+9.7% CC*)

* Constant Currency (CC) excluding the impact of FX

slide-18
SLIDE 18

€0 €200 €400 €600 €800 €1,000 €1,200 €1,400

FY15 FX Volume Price FY16

Revenue Growth by Segment - GN

2016 Full Year Results | Slide 18

US Cheese €743m Nutritional Solutions €475m

Glanbia Nutritionals Revenue growth +0.5% (+0.4% CC*)

* Constant Currency (CC) excluding the impact of FX

Million

€1,218m 0.1% 3.2% (2.8)% €1,224m FY15 FY16

US Cheese €736m Nutritional Solutions €488m

slide-19
SLIDE 19

EBITA Progression

2016 Full Year Results | Slide 19

€200 €220 €240 €260 €280 €300

FY15 FX Glanbia Nutritionals Dairy Ireland FY16 €271.0m €0.3m €27.1m €4.8m €1.9m €305.1m Million

Wholly owned EBITA growth +12.6% (+12.5% CC*)

* Constant Currency (CC) excluding the impact of FX

Glanbia Performance Nutrition

slide-20
SLIDE 20

Exceptional Items Summary

2016 Full Year Results | Slide 20

€'m 2016 2015

  • 1. Organisation redesign costs

(11.4) (7.0)

  • 2. Acquisition integration costs

(3.1) (2.9)

  • 3. Rationalisation costs

(3.0) (7.8)

  • 4. Irish defined benefit pension plans
  • (5.0)
  • 5. Disposal of Joint Venture
  • (3.6)

Total exceptional charge before tax (17.5) (26.3) Tax credit on exceptional items 2.7 2.5 Total exceptional charge (14.8) (23.8)

slide-21
SLIDE 21

Cash Flow Progression

2016 Full Year Results | Slide 21 * Depreciation includes Grant Amortisation NOTE: 2016 EBITA reflects the wholly-owned business

€305m €50m €32m €14m €(32m) €(53m) €(4m) €354m €311m €256m €153m €120 €170 €220 €270 €320 €370

Million

2016 EBITA Depreciation* Working Capital Business Sustaining Capex 2016 Operating Cash Flow Net Interest & Tax Dividends from JV&A's Other 2016 Free Cash Flow FCF 2015 FCF 2014

Free Cash Flow +22% converting 88% of EBITDA to cash

slide-22
SLIDE 22

Investment and Returns

2016 2015 2014

€73m

2016 Full Year Results | Slide 22

€116m 116m €124m 124m €90m 90m

€86m €57m €43m €37m €32m

ROCE

12.9%

  • 100bps

Strategic Capex

  • Bus. Sustaining Capex

* Inclusive of estimated contingent consideration

Total Capex

slide-23
SLIDE 23

Balance Sheet

2016 Full Year Results | Slide 23

Financing KPI's 2016 2015 Net Debt €438 million €584 million Net Debt / Adjusted EBITDA¹ 1.19 times 1.75 times Adjusted EBIT¹ / Net Finance Cost 11.5 times 10.8 times

  • 1. The definition of adjusted EBITDA and adjusted EBIT are as per our financing agreements and include dividends from Joint Ventures & Associates
  • Available bank facilities of:
  • €722 million revolving credit facilities maturing January 2020
  • $325 million private debt placement of senior loan notes, due June 2021
  • Net pension obligations of €110.5 million* of which approximately €60 million* relate

to Dairy Ireland

*on an IAS 19 basis

slide-24
SLIDE 24

2016 Full Year Results | Slide 24

Proposed sale of 60% interest in Dairy Ireland to Glanbia Coop

Process and financing

Final agreements to be completed and shareholder approval required by plc and Coop Expected to close by mid 2017 100% of the actual working capital in Dairy Ireland will be acquired by “Glanbia Ireland” on completion Transaction expected to be 5% - 7% Adjusted EPS dilutive

Expected consideration*** to PLC 60% equity interest €112m 3 year Avg. working capital €92.5m

* Enterprise Value is an approximate amount based upon the total of Equity value plus 3 year average working capital plus pension liabilities associated with Dairy Ireland ** Equity value is net of pension obligations associated with Dairy Ireland and 3 year average working capital *** Note final consideration will be the total value of 100% of the actual working capital at completion plus equity value

Valuation Enterprise Value (EV of 100%)* €340m Equity value (100%)** €186m

slide-25
SLIDE 25

Summary & Outlook

slide-26
SLIDE 26

Summary & Outlook

2016 Full Year Results | Slide 26

*Pro-forma adjusted EPS of the continuing Group has been calculated assuming the Dairy Ireland transaction was completed at the start of FY 2016. **Continuing Group as used above includes “Glanbia Ireland” as a 40% associate ***The Dairy Ireland transaction is contingent upon agreement of legal transaction contracts and shareholder approvals

slide-27
SLIDE 27

Questions & Answers

slide-28
SLIDE 28

Appendix

slide-29
SLIDE 29

2016 Full Year Results | Slide 29

Appendix – Non IFRS Performance Measures

1. To arrive at the constant currency year–on–year change, the results for the prior year are retranslated using the average exchange rates for the current year and compared to the current year reported numbers. 2. Revenue comprises sales of goods and services of the wholly owned businesses to external customers net of value added tax, rebates and discounts. 3. EBITA is defined as earnings before interest, tax and amortisation excluding exceptional items. 4. EBITA margin is defined as EBITA before exceptional items as a percentage of the revenue of the wholly owned businesses. 5. Total Group is used to describe certain financial metrics such as Revenue and EBITA when they include both the wholly owned businesses and the Group's share of Joint Ventures & Associates. 6. Adjusted EPS is defined as the net profit attributable to the equity holders of Glanbia plc, before exceptional items and intangible asset amortisation, net of related tax, divided by the weighted average number of ordinary shares in issue during the year. 7. Free cash flow is calculated as the net cash flow in the year before the following items: strategic capital expenditure, acquisition spend, proceeds received on disposals, equity dividends paid, exceptional costs paid, loans to Joint Ventures & Associates and currency translation movements. 8. Net debt : adjusted EBITDA is calculated as net debt at the end of the year divided by adjusted EBITDA. Net debt is calculated as total financial liabilities (excluding debt issue costs) less cash and cash equivalents. Adjusted EBITDA is calculated as EBITDA for the wholly owned businesses (as defined under operating cash flow) plus dividends received from Joint Ventures & Associates, and in the event of an acquisition in the year, includes pro–forma EBITDA as though the acquisition date had been at the beginning of the year. 9. ROCE is defined as the Group's earnings before interest, tax and amortisation (net of related tax) plus the Group's share of the results

  • f Joint Ventures & Associates after interest and tax divided by capital employed. Capital employed comprises the sum of the Group's

total assets plus cumulative intangible asset amortisation less current liabilities but excluding all financial liabilities, retirement benefit assets, cash and deferred tax balances. It is calculated by taking the average of the relevant opening and closing balance sheet

  • amounts. In years where the Group makes significant acquisitions or disposals, the ROCE calculation is adjusted appropriately, to

ensure the acquisition or disposal are equally time apportioned in the numerator and the denominator.

slide-30
SLIDE 30

Email: ir@glanbia.ie Tel: +353 56 777 2200

Delivering better nutrition for every step of life’s journey

Liam Hennigan Head of Investor Relations Glanbia plc Glanbia House Kilkenny, Ireland